1-151404946-A-C
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 1P and 20B. PP2BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000271715.7(POGZ):āc.4089T>Gā(p.His1363Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00128 in 1,614,140 control chromosomes in the GnomAD database, including 6 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. H1363R) has been classified as Likely benign.
Frequency
Consequence
ENST00000271715.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
POGZ | NM_015100.4 | c.4089T>G | p.His1363Gln | missense_variant | 19/19 | ENST00000271715.7 | NP_055915.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
POGZ | ENST00000271715.7 | c.4089T>G | p.His1363Gln | missense_variant | 19/19 | 1 | NM_015100.4 | ENSP00000271715 | P3 |
Frequencies
GnomAD3 genomes AF: 0.00112 AC: 170AN: 152140Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.00132 AC: 331AN: 251476Hom.: 0 AF XY: 0.00152 AC XY: 206AN XY: 135916
GnomAD4 exome AF: 0.00129 AC: 1893AN: 1461882Hom.: 5 Cov.: 36 AF XY: 0.00140 AC XY: 1018AN XY: 727242
GnomAD4 genome AF: 0.00112 AC: 170AN: 152258Hom.: 1 Cov.: 32 AF XY: 0.00101 AC XY: 75AN XY: 74448
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Jun 24, 2019 | This variant is associated with the following publications: (PMID: 26942287, 26739615) - |
Likely benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | May 03, 2017 | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2024 | POGZ: BP4, BS1 - |
Inborn genetic diseases Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 18, 2018 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
POGZ-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Dec 21, 2021 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Intellectual disability-microcephaly-strabismus-behavioral abnormalities syndrome Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Apr 11, 2023 | - - |
Autism spectrum disorder Other:1
association, no assertion criteria provided | clinical testing | Center of Medical Genetics, Central South University | - | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at